Fingerprint
Dive into the research topics of 'Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: Commentary'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: Commentary
Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops
*Corresponding author for this work
Research output: Contribution to journal › Comment/debate › peer-review